Logo image of HTPA

HIGHLAND TRANSCEND PART-CL A (HTPA) Stock Fundamental Analysis

NYSE:HTPA - New York Stock Exchange, Inc. - KYG446901087 - Common Stock - Currency: USD

10.05  -0.01 (-0.1%)

Fundamental Rating

2

Taking everything into account, HTPA scores 2 out of 10 in our fundamental rating. HTPA was compared to 0 industry peers in the Unkown industry. While HTPA seems to be doing ok healthwise, there are quite some concerns on its profitability. HTPA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HTPA had positive earnings in the past year.
In the past year HTPA has reported a negative cash flow from operations.
HTPA Yearly Net Income VS EBIT VS OCF VS FCFHTPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA 6.85%
ROE 7.25%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTPA Yearly ROA, ROE, ROICHTPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -1 -2 -3 -4

1.3 Margins

HTPA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HTPA Yearly Profit, Operating, Gross MarginsHTPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

HTPA has less shares outstanding than it did 1 year ago.
The debt/assets ratio for HTPA is higher compared to a year ago.
HTPA Yearly Shares OutstandingHTPA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 10M 20M 30M
HTPA Yearly Total Debt VS Total AssetsHTPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 100M 200M 300M

2.2 Solvency

HTPA has an Altman-Z score of 13.36. This indicates that HTPA is financially healthy and has little risk of bankruptcy at the moment.
HTPA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.36
ROIC/WACCN/A
WACCN/A
HTPA Yearly LT Debt VS Equity VS FCFHTPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 50M 100M 150M 200M 250M

2.3 Liquidity

HTPA has a Current Ratio of 0.04. This is a bad value and indicates that HTPA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.04 indicates that HTPA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
HTPA Yearly Current Assets VS Current LiabilitesHTPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

HTPA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -7240.68%.
EPS 1Y (TTM)-7240.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 18.60% on average over the next years. This is quite good.
HTPA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.78% yearly.
EPS Next Y97.36%
EPS Next 2Y41.2%
EPS Next 3Y25.75%
EPS Next 5Y18.6%
Revenue Next Year65.48%
Revenue Next 2Y55.19%
Revenue Next 3Y49.52%
Revenue Next 5Y41.78%

3.3 Evolution

HTPA Yearly Revenue VS EstimatesHTPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
HTPA Yearly EPS VS EstimatesHTPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.27, which indicates a rather expensive current valuation of HTPA.
Compared to an average S&P500 Price/Earnings ratio of 29.62, HTPA is valued a bit cheaper.
The Forward Price/Earnings Ratio is negative for HTPA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 18.27
Fwd PE N/A
HTPA Price Earnings VS Forward Price EarningsHTPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HTPA Per share dataHTPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

HTPA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HTPA's earnings are expected to grow with 25.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y41.2%
EPS Next 3Y25.75%

More info and screens

0

5. Dividend

5.1 Amount

HTPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIGHLAND TRANSCEND PART-CL A

NYSE:HTPA (12/5/2022, 8:04:00 PM)

10.05

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)04-04 2022-04-04/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap376.88M
Analysts82.86
Price Target18.36 (82.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.27
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)0.55
EY5.47%
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS7.61
TBVpS7.61
PEG (NY)0.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.85%
ROE 7.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 13.36
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7240.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.91%
EPS Next Y97.36%
EPS Next 2Y41.2%
EPS Next 3Y25.75%
EPS Next 5Y18.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year65.48%
Revenue Next 2Y55.19%
Revenue Next 3Y49.52%
Revenue Next 5Y41.78%
EBIT growth 1Y-2516.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.14%
EBIT Next 3Y23.67%
EBIT Next 5Y16.21%
FCF growth 1Y33.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.66%
OCF growth 3YN/A
OCF growth 5YN/A